4//SEC Filing
Chevallard Daniel R. 4
Accession 0001209191-24-004825
CIK 0001061027other
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 8:29 PM ET
Size
6.0 KB
Accession
0001209191-24-004825
Insider Transaction Report
Form 4
Chevallard Daniel R.
Chief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-03-12+200,000→ 200,000 totalExercise: $0.98Exp: 2034-03-12→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]1/48th of the total shares subject to the Option will vest each month on the same day of the month as the Vesting Commencement Date (as defined below), and if there is no corresponding day, the last day of the month, subject to the Reporting Person continuing to be a Service Provider in accordance with the Company's 2021 Equity Incentive Plan through each such date. The Vesting Commencement Date is January 1, 2024.
Documents
Issuer
Viracta Therapeutics, Inc.
CIK 0001061027
Entity typeother
Related Parties
1- filerCIK 0001706176
Filing Metadata
- Form type
- 4
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 8:29 PM ET
- Size
- 6.0 KB